Superdisntegrants Market, By Product (Crospovidone, Croscarmellose sodium, Ion Exchange Resin, Sodium Starch Glycolate, Others), by Dosage Form, by Geography (NA, EU, APAC, and RoW) Analysis, Share, Trends, Size, & Forecast From 2014 2025
REPORT HIGHLIGHT
The superdisintegrants market was valued at USD 380.2 million by 2017, growing with 8.1% CAGR during the forecast period, 2018-2025
Market Dynamics
In contemporary oral medicines, disintegrants are added for aiding a quick dilution of the tablet in an aqueous environment and complementing a spontaneous release of the drug substance. A new genre of disintegrants has emerged in the market that is known as superdisintegrants. Natural products are biodegradable, chemically inert, and widely available. The good thing about it is you can customize it in several ways to dispense a system of drug delivery. Mucilages and natural gums are among the two widely used pharmaceutical superdisintegrants.
In modern oral medicines, these products are used in the form of emulsifiers, stabilizers, gelling agent, granulating agent, thickener, binder, and film former in the pharmaceutical industry. Over the years the demand for superdisintegrants made from natural sources has sky-rocketed because they are readily available and economically priced. Moreover, they are non-irritant and deliver soothing action.
Further, the natural product will receive a boost by virtue of being eco-friendly, and adaptable to several chemical modifications which make them compatible with different kinds of medicines. However, concerns over safety and quality are going to impede the market growth of superdisintegrants to large extent in the forecasted period.
Product Takeaway
The industry is segmented into natural, synthetic, and others. The synthetic products are further categorized into cross-linked polyvinylpyrrolidone (crospovidone), modified cellulose, calcium silicates, and ion exchange resins. In 2017, Crospovidone had the biggest revenue share. One of the reasons for such dominance in the market could be attributed to its higher crosslinking density. As a result, it swells rapidly in water without taking the form of a gel. It has a unique particle morphology featuring highly compressible materials.
Croscarmellose sodium is an FDA approved superdisintegrants that works on the principles of cross-linking paving the way for a much-improved bioavailability through superior drug dissolution. The use of this substance has been deemed safe by FDA when used in normal quantities.
Dosage Form Insights
The industry, in 2017, was dominated by solid dosage forms i.e. capsules and tablets. Superdisintegrants are one of the most important excipients of capsule and tablet formulation because they are capable of inducing breakups the moment it comes into contact with aqueous fluid. Capsules and tablets have quick dissolving dosage form duly recognized by FDA. The doses are listed in the catalog of approved drug products along with therapeutic equivalence evaluations that would be boosting the segment’s growth. The number of disintegrates having usage in multifunctional tablet and capsule formulation is inclusive of starch, crospovidone, cellulose, and others. Mouth dissolving films segment will experience the highest growth during the forecasted period. Ability to rapidly disintegrate and dissolve in the oral cavity, accurate dosing, quick action, better patient compliance for the pediatric population are the factors propelling the growth of the segment.
Regional Takeaway
North America is the dominant region owing to the surging demand for generic drugs, better innovation in the manufacturing of this chemical product. It is anticipated that by virtue of increased outsourcing of excipients the Asia Pacific region will grow at the fastest CAGR along with manufacturing of the latest superdisintegrants, and incorporation of novel technologies.
The emergence of pharmaceutical giants in the region with humungous production capabilities and high consumption of excipients provides a befitting explanation for the large share of this region. Moreover, the ever-increasing demand for superior pharmaceutical products and generics will provide the necessary impetus for sustainable growth in the region.
Key Vendor Takeaways
Currently, the industry is fragmented in itself with the presence of numerous key vendors. The companies that dominate the global market are Ashland Global Holdings, Inc., FMC Corporation, DFE Pharma, Nippon Soda Co., Ltd., Dow Pharma Solutions, and BASFStrategic undertakings of these companies to increase their revenue share over the future period emphasizes on mergers, acquisition, and regional expansions.
The market size and forecast for each segment and sub-segments has been considered as below:
- Historical Year – 2014 & 2016
- Base Year – 2017
- Estimated Year – 2018
- Projected Year – 2025
TARGET AUDIENCE
- Traders, Distributors, and Suppliers
- Manufacturers
- Government and Regional Agencies and Research Organizations
- Consultants
- Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
MARKET, BY PRODUCT
- Crospovidone
- Croscarmellose sodium
- Ion Exchange Resin
- Sodium Starch Glycolate
- Others
MARKET, BY DOSAGE FORM
- Solid Dosage Form
- Mouth-dissolving Films
MARKET, BY REGION
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- Rest of Europe
- Asia Pacific
- India
- China
- Rest of APAC
- Rest of the World
- Middle East and Africa
- Latin America
TABLE OF CONTENT
1. SUPERDISNTEGRANTS MARKET OVERVIEW
1.1. Study Scope
1.2. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Key Market Facts
2.2. Geographical Scenario
2.3. Companies in the Market
3. SUPERDISNTEGRANTS KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. SUPERDISNTEGRANTS INDUSTRY STUDY
4.1. Porter’s Analysis
4.2. Market Attractiveness Analysis
4.3. Regulatory Framework Analysis
5. SUPERDISNTEGRANTS MARKET LANDSCAPE
5.1. Market Share Analysis
6. SUPERDISNTEGRANTS MARKET – BY PRODUCT
6.1. Overview
6.2. Crospovidone
6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.3. Croscarmellose sodium
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.4. Ion Exchange Resin
6.4.1. Overview
6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.5. Sodium Starch Glycolate
6.5.1. Overview
6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.6. Others
6.6.1. Overview
6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7. SUPERDISNTEGRANTS MARKET– BY DOSAGE FORM
7.1. Introduction
7.2. Solid Dosage Form
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.3. Mouth-dissolving Films
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8. SUPERDISNTEGRANTS MARKET– BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. Overview
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.2.3. U.S.
8.2.3.1. Overview
8.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.2.4. Canada
8.2.4.1. Overview
8.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.3. Europe
8.3.1. Overview
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.3.3. France
8.3.3.1. Overview
8.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.3.4. Germany
8.3.4.1. Overview
8.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.3.5. Rest of Europe
8.3.5.1. Overview
8.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.4. Asia Pacific (APAC)
8.4.1. Overview
8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.4.3. China
8.4.3.1. Overview
8.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.4.4. India
8.4.4.1. Overview
8.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.4.5. Rest of APAC
8.4.5.1. Overview
8.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.5. Rest of the World
8.5.1. Overview
8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.5.3. Latin America
8.5.3.1. Overview
8.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.5.4. Middle East and Africa
8.5.4.1. Overview
8.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9. KEY VENDOR ANALYSIS
9.1. Overview
9.2. Ashland Global Holdings, Inc.
9.2.1. Company Overview
9.2.2. SWOT Analysis
9.2.3. Key Developments
9.3. FMC Corporation
9.3.1. Company Overview
9.3.2. SWOT Analysis
9.3.3. Key Developments
9.4. DFE Pharma
9.4.1. Company Overview
9.4.2. SWOT Analysis
9.4.3. Key Developments
9.5. Nippon Soda Co. Ltd.
9.5.1. Company Overview
9.5.2. SWOT Analysis
9.5.3. Key Developments
9.6. Dow Pharma Solutions
9.6.1. Company Overview
9.6.2. SWOT Analysis
9.6.3. Key Developments
9.7. BASF
9.7.1. Company Overview
9.7.2. SWOT Analysis
9.7.3. Key Developments
10. 360 DEGREE ANALYSTVIEW
11. APPENDIX
11.1. Research Methodology
11.2. Abbreviations
11.3. Disclaimer
11.4. Contact Us
List of Tables
Table 1 List of Acronyms
Table 2 Key Market Facts, 2014 – 2025
Table 3 Market Drivers: Impact Analysis
Table 4 Market Restraint: Impact Analysis
Table 5 Market Opportunity: Impact Analysis
Table 6 PEST Analysis
Table 7 Porter’s Five Forces Analysis
Table 8 Company Market Share Analysis
Table 9 Global Superdisntegrants Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
Table 10 Superdisntegrants Market, by Product, 2014 – 2025 (USD Billion)
Table 11 Superdisntegrants Market, by Dosage Form, 2014 – 2025 (USD Billion)
Table 12 Superdisntegrants Market, by Geography, 2014 – 2025 (USD Billion)
Table 13 North America Superdisntegrants Market, 2014 – 2025 (USD Billion)
Table 14 U.S. Superdisntegrants Market, 2014 – 2025 (USD Billion)
Table 15 Canada Superdisntegrants Market, 2014 – 2025 (USD Billion)
Table 16 Europe Superdisntegrants Market, 2014 – 2025 (USD Billion)
Table 17 France Superdisntegrants Market, 2014 – 2025 (USD Billion)
Table 18 Germany Superdisntegrants Market, 2014 – 2025 (USD Billion)
Table 19 Asia Pacific Superdisntegrants Market, 2014 – 2025 (USD Billion)
Table 20 China Superdisntegrants Market, 2014 – 2025 (USD Billion)
Table 21 India Superdisntegrants Market, 2014 – 2025 (USD Billion)
Table 22 Latin America Superdisntegrants Market, 2014 – 2025 (USD Billion)
Table 23 MEA Superdisntegrants Market, 2014 – 2025 (USD Billion)
List of Figures
Figure 1 Research Methodology
Figure 2 Research Process Flow Chart
Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)
Figure 4 Regulatory Framework Analysis
Figure 5 Superdisntegrants Market, by Product, 2014 – 2025 (USD Billion)
Figure 6 Superdisntegrants Market, by Dosage Form, 2014 – 2025 (USD Billion)
Figure 7 Superdisntegrants Market, by Geography, 2014 – 2025 (USD Billion)
